Akebia Therapeutics Inc. buy HC Wainwright
Start price
15:00
/
50%
€1.26
Target price
06.09.25
€6.74
Performance (%)
-1.43%
Price
16:36
€1.24
Summary
This prediction is currently active. With a performance of -1.43%, the BUY prediction by HC_Wainwright is trending in the wrong direction. This prediction currently runs until 06.09.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Akebia Therapeutics Inc. | -1.43% |
iShares Core DAX® | -1.414% |
iShares Nasdaq 100 | -2.316% |
iShares Nikkei 225® | -2.756% |
iShares S&P 500 | -1.849% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.50 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-31.80%
16:36
16:36
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
32.72%
16:36
16:36
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
11.87%
16:36
16:36
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
28.08.23
28.08.23
€3.47
28.08.24
28.08.24
9.45%
29.08.24
29.08.24